MONTELEONE, Palmiero
 Distribuzione geografica
Continente #
NA - Nord America 32.051
AS - Asia 17.051
EU - Europa 11.042
SA - Sud America 1.680
AF - Africa 266
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 40
Totale 62.173
Nazione #
US - Stati Uniti d'America 31.710
HK - Hong Kong 5.704
SG - Singapore 4.737
IT - Italia 4.398
CN - Cina 2.658
UA - Ucraina 2.101
VN - Vietnam 1.470
BR - Brasile 1.192
DE - Germania 992
TR - Turchia 787
RU - Federazione Russa 683
IE - Irlanda 629
FR - Francia 621
KR - Corea 500
FI - Finlandia 496
SE - Svezia 476
IN - India 335
AR - Argentina 200
BD - Bangladesh 195
GB - Regno Unito 179
CA - Canada 137
IQ - Iraq 117
JP - Giappone 111
MX - Messico 101
EC - Ecuador 74
AT - Austria 67
ZA - Sudafrica 62
PK - Pakistan 61
ID - Indonesia 60
NL - Olanda 60
PL - Polonia 59
CO - Colombia 52
VE - Venezuela 51
ES - Italia 49
EU - Europa 35
MA - Marocco 35
AU - Australia 34
MY - Malesia 34
UZ - Uzbekistan 32
PH - Filippine 31
CL - Cile 30
JO - Giordania 30
KE - Kenya 30
SA - Arabia Saudita 28
EG - Egitto 27
BE - Belgio 26
PY - Paraguay 25
PE - Perù 24
TN - Tunisia 24
CZ - Repubblica Ceca 20
IL - Israele 20
NO - Norvegia 18
NP - Nepal 18
CH - Svizzera 17
RO - Romania 17
BG - Bulgaria 16
DZ - Algeria 16
AE - Emirati Arabi Uniti 15
CR - Costa Rica 15
JM - Giamaica 15
LT - Lituania 15
GT - Guatemala 14
UY - Uruguay 14
BO - Bolivia 13
ET - Etiopia 13
HU - Ungheria 11
PA - Panama 11
PT - Portogallo 11
RS - Serbia 11
SN - Senegal 11
AL - Albania 10
AZ - Azerbaigian 10
DO - Repubblica Dominicana 10
GR - Grecia 9
HN - Honduras 9
HR - Croazia 9
LB - Libano 9
NG - Nigeria 9
NZ - Nuova Zelanda 9
PS - Palestinian Territory 9
IR - Iran 8
KZ - Kazakistan 8
KG - Kirghizistan 7
OM - Oman 7
SV - El Salvador 7
BN - Brunei Darussalam 6
GH - Ghana 6
MD - Moldavia 6
SY - Repubblica araba siriana 6
TW - Taiwan 6
BA - Bosnia-Erzegovina 5
MN - Mongolia 5
AO - Angola 4
GE - Georgia 4
KW - Kuwait 4
LU - Lussemburgo 4
LV - Lettonia 4
MK - Macedonia 4
PR - Porto Rico 4
CW - ???statistics.table.value.countryCode.CW??? 3
Totale 62.081
Città #
Ann Arbor 6.775
Hong Kong 5.685
Woodbridge 2.664
Jacksonville 2.560
Singapore 2.440
Wilmington 2.308
Chandler 2.162
Princeton 1.910
San Jose 1.758
Milan 1.757
Houston 1.720
Ashburn 1.278
Dallas 1.114
Izmir 728
Council Bluffs 623
Dublin 620
Dong Ket 610
The Dalles 511
Nanjing 510
Andover 481
Lauterbourg 469
Rome 465
Boardman 366
Beijing 359
Memphis 353
Pellezzano 338
Ho Chi Minh City 294
Moscow 244
Düsseldorf 241
Naples 221
Hanoi 207
Hebei 178
Fairfield 171
Shenyang 167
Pune 165
Norwalk 162
Mestre 160
Nanchang 157
Santa Clara 143
Los Angeles 140
Changsha 130
New York 119
Jiaxing 118
Frankfurt am Main 113
Figino 102
São Paulo 102
Tokyo 97
Turin 97
Seattle 86
Salerno 81
Washington 77
Tianjin 76
Redwood City 67
Munich 63
Nuremberg 59
Des Moines 55
Da Nang 54
San Nicola la Strada 50
Orem 49
Brooklyn 47
Baghdad 46
Chicago 46
Rio de Janeiro 46
Warsaw 45
San Diego 42
Atlanta 40
Amsterdam 37
San Francisco 35
Edinburgh 34
Helsinki 33
Belo Horizonte 32
Cambridge 32
Toronto 32
Boston 31
Columbus 30
Chennai 29
Florence 29
Amman 28
Dhaka 28
Tashkent 28
Bologna 27
Dearborn 27
Nettuno 27
Haiphong 26
Hải Dương 25
Montreal 25
Jinan 24
Guayaquil 23
Nairobi 23
Quito 23
Sant'Anastasia 23
Vienna 23
Brussels 22
Johannesburg 22
London 22
Shanghai 22
Catania 21
Mumbai 21
Biên Hòa 20
Brasília 20
Totale 46.025
Nome #
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. 1.276
Early traumatic experiences and eating disorders: A focus on the endogenous stress response system 656
Assenza di modulazione GABAergica sulla secrezione basale di prolattina e di GH nella schizofrenia cronica 468
Circadian rhythms and treatment implications in depression 464
No association of the Arg51Gln and Leu72Met polymorphisms of the ghrelin gene with anorexia nervosa or bulimia nervosa 447
Enhanced response of ghrelin to sham feeding in patients with anorexia nervosa 434
Accuracy of self-assessment of real-life functioning in schizophrenia 368
Lowered serum dipeptidyl peptidase IV activity in patients with anorexia and bulimia nervosa 355
Ghrelin response to hedonic eating in underweight and short-term weight restored patients with anorexia nervosa 354
Significant Locus and Metabolic Genetic Correlations Revealed in Genome-Wide Association Study of Anorexia Nervosa 325
Health-related quality of life in euthymic bipolar disorder patients: Differences between bipolar I and II subtypes 265
Circulating levels of neuroactive steroids in patients with binge eating disorder: a comparison with nonobese healthy controls and non-binge eating obese subjects 243
Serotonin transporter polymorphism and potential response to SSRIs in bulimia nervosa. 230
Physical exercise at night blunts the nocturnal increase of plasma melatonin levels in healthy humans 220
Appropriatezza clinica, strutturale e operativa nella prevenzione, diagnosi e terapia dei disturbi dell’alimentazione 218
Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning 218
Melanocortin-4 receptor molecular scanning and pro-opiomelanocortin R236G variant screening in binge eating disorder 209
Childhood trauma and cortisol awakening response in symptomatic patients with anorexia nervosa and bulimia nervosa 209
A 4-year epidemiological study of typical and atypical eating disorders: preliminary evidence for subgroups of atypical eating disorders with different natural outcomes 194
The human pineal gland responds to stress-induced sympathetic activation in the second half of the dark phase: preliminary evidence 190
Altered processing of rewarding and aversive basic taste stimuli in symptomatic women with anorexia nervosa and bulimia nervosa: An fMRI study 185
3111T/C polymorphism of the clock gene confers a predisposition to a lifetime lower body weight in anorexia and bulimia nervosa 180
An epidemiological study on eating disorders in two high schools in Naples 177
Pharmacological activation of the GABAergic system does not affect GH and PRL release in acromegaly 172
Altered immunoreactive levels of G proteins in peripheral mononuclear cells of patients with anorexia nervosa and bulimia nervosa 170
Leptin secretion is related to chronicity and severity of the illness in bulimia nervosa 167
Lateralization patterns of verbal stimuli processing assessed by reaction time and event-related potentials in schizophrenic patients 166
Regolazione del comportamento alimentare e correlati biochimici dell’anoressia e bulimia nervosa 166
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects 166
Serotonergic modulation of rat pineal gland activity: in vivo evidence for a 5-Hydroxytryptamine(2C) receptor involvement 165
Alterazioni neuroendocrine nella depressione stagionale 161
Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa 161
Aggressive behavioral characteristics and endogenous hormones in women with Bulimia nervosa 159
Differences between morning and afternoon hormonal responses to D-fenfluramine in healthy humans 159
(+)-N-allylnormetazocine enhances N-acetyltransferase activity and melatonin synthesis: preliminary evidence for a functional role of sigma receptors in the rat pineal gland 159
Growth hormone response to GABA?B receptor activation in depressed patients before and after antidepressant therapy 158
The 196G/A (val66met) polymorphism of the BDNF gene is significantly associated with binge eating behavior in women with bulimia nervosa or binge eating disorder 157
Chronic antidepressant drug treatment does not affect GH response to baclofen in depressed subjects 156
The family of a patient with an eating disorder 155
Interhemispheric functional connectivity in anorexia and bulimia nervosa 155
Are antipsychotics useful in the treatment of anorexia nervosa? 152
[Evaluation of therapeutic efficacy and pharmacokinetics of controlled release of trazodone in patients with major depressive disorder] 152
Correlations between negative symptoms and peripheral G protein levels in mononuclear leukocytes of deficit and nondeficit schizophrenics. Preliminary results 151
Serotonin Trasporter Polymorphisms And Ssri Response In Bulimia Nervosa 151
The treatment of unipolar depression by lithium salts 150
Evidence for opiate and estrogen interaction on neurohormonal secretion 150
Evidence that cholinergic receptors of muscarinic type may modulate vasopressin release induced by metoclopramide 150
The circadian basis of mood disorders: Recent developments and treatment implications 149
Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report. 148
NEUROENDOCRINOLOGY OF EATING DISORDERS: RECENT ADVANCES AND FUTURE PERSPECTIVES 147
A comparative study of melatonin production in the retina, pineal gland and harderian gland of Bufo viridis and Rana esculenta 147
Melatonin and cortisol secretion in patients with primary obsessive-compulsive disorder 147
Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine 146
Self-injurious behavior and attempted suicide in purging bulimia nervosa: Associations with psychiatric comorbidity 146
Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect 146
Baclofen-induced growth hormone secretion is blunted in chronic schizophrenics: neuroendocrine evidence for a GABA disturbance in schizophrenia 145
Differences in Cortisol Awakening Response between Binge-Purging and Restrictive Patients with Anorexia Nervosa 145
Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia a network analysis 145
Alexithymia and cortisol awakening response in people with eating disorders 145
Neuroendocrine effect of short term activation of GABAergic system in schizophrenics with and without tardive dyskinesia 144
Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity 144
Naloxone-induced decrease of plasma prolactin in healthy women 143
Development and validation of the family coping questionnaire for eating disorders 142
Aripiprazole augmentation strategy in clomipramine-resistant depressive patients: an open preliminary study. 142
The acute salivary ghrelin response to a psychosocial stress is enhanced in symptomatic patients with bulimia nervosa: a pilot study. 142
Psychobiology of eating disorders 142
Impulsiveness in patients with bulimia nervosa: electrophysiological evidence of reduced inhibitory control. 142
Test alla d-fenfluramina e risposta al trattamento farmacologico nei pazienti con sindrome ossessivo-compulsiva 142
A genome-wide association study of anorexia nervosa suggests a risk locus implicated in dysregulated leptin signaling 142
Effect of pharmacological activation of gamma?aminobutyric acid system on basal pituitary secretion in humans 141
Brain-derived neurtrophic factor in mood disorders: reply to Kapczinski et al.’s comment 141
Association of a functional serotonin transporter gene polymorphism with binge eating disorder 140
Combined alpha-adrenergic stimulation results in biphasic response of growth hormone release in man 139
Underweight subjects with anorexia nervosa have an enhanced salivary cortisol response not seen in weight restored subjects with anorexia nervosa 139
Asymmetry of salivary cortisol and α-amylase responses to psychosocial stress in anorexia nervosa but not in bulimia nervosa 138
PLASMA LEPTIN AND WEIGHT GAIN DURINO CLOZAPINE TREATMENT 138
Circadian Rhythm disturbances in depression: implications for treatment and quality of remission 136
Dysfunctions of leptin, ghrelin, BDNF and endocannabinoids in eating disorders: beyond the homeostatic control of food intake. 136
Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa 136
Association between A218C polymorphism of the tryptophan-hydroxylase-1 gene, harm avoidance and binge eating behavior in bulimia nervosa 136
Risposta della prolattina alla d-fenfluramina in pazienti con sindrome ossessivo-compulsiva prima e dopo terapia con fluvoxamina 136
The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia 136
Effects of acute and chronic haloperidol administration on the nocturnal activity of the rat pineal gland in vivo 135
G-PROTEIN IMMUNOREACTIVITY LEVELS IN LYMPHOCYTES OF DEFICIT AND NONDEFICIT SCHIZOPHRENIC PATIENTS 134
Psicobiologia dei disturbi del comportamento alimentare 134
Anoressia e Bulimia Nervosa - NOOS 133
2-[125]Iodomelatonin binding sites in the brain retina and Harderian gland of the green frog Rana esculenta 133
Plasma melatonin and cortisol circadian patterns in patients with obsessive-compulsive disorder before and after fluoxetine treatment 132
Leptin production in bulimia nervosa 132
LEPTIN AND ITS SOLUBILE RECEPTOR ACROSS THE EATING DISORDER SPECTRUM 131
Investigation of factors associated to crossover from anorexia nervosa restricting type (ANR) and anorexia nervosa binge-purging type (ANBP) to bulimia nervosa and comparison of bulimia nervosa patients with or without previous ANR or ANBP 131
Acute trazodone administration decreases plasma cortisol levels in healthy subjects. 130
INVESTIGATION OF NEUROACTIVE STEROIDS IN ANOREXIA AND BULIMIA NERVOSA 130
Effects of single and repeated electroconvulsive shock on isoproterenol-stimulated pineal N-acetyltransferase activity and melatonin production in rats 130
Brain-derived neurotrophic factor (BDNF) and eating behaviour in bulimia nervosa and binge eating disorder 130
How do relatives cope with eating disorders? Results from an Italian multicentre study 130
Psychiatric syndromes in infectious diseases 129
Opposite changes in circulating adiponectin in women with bulimia nervosa or binge eating disorder 129
Blood levels of mianserin and amitriptyline and clinical response in aged depressed patients 129
Seasonal variation in plasma prolactin response to D-fenfluramine in healthy subjects 129
Totale 19.027
Categoria #
all - tutte 200.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 200.536


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.332 9 4 18 29 36 22 50 129 517 439 445 1.634
2022/20235.458 616 249 224 479 786 1.162 23 607 737 39 405 131
2023/20242.575 226 332 174 78 153 420 147 241 42 158 201 403
2024/20254.338 328 78 131 148 164 561 610 704 672 194 355 393
2025/202622.629 1.384 2.949 3.484 666 2.189 1.243 3.609 717 1.043 1.895 663 2.787
2026/2027285 285 0 0 0 0 0 0 0 0 0 0 0
Totale 63.352